These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


432 related items for PubMed ID: 7473818

  • 1. Characterization of extensive genetic alterations in ductal carcinoma in situ by fluorescence in situ hybridization and molecular analysis.
    Murphy DS, Hoare SF, Going JJ, Mallon EE, George WD, Kaye SB, Brown R, Black DM, Keith WN.
    J Natl Cancer Inst; 1995 Nov 15; 87(22):1694-704. PubMed ID: 7473818
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Extensive ductal carcinoma In situ with small foci of invasive ductal carcinoma: evidence of genetic resemblance by CGH.
    Aubele M, Mattis A, Zitzelsberger H, Walch A, Kremer M, Welzl G, Höfler H, Werner M.
    Int J Cancer; 2000 Jan 01; 85(1):82-6. PubMed ID: 10585588
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Chromosome 1 aneusomy, identified by interphase cytogenetics, in mammographically detected ductal carcinoma in situ of the breast.
    Harrison M, Magee HM, O'Loughlin J, Gorey TF, Dervan PA.
    J Pathol; 1995 Mar 01; 175(3):303-9. PubMed ID: 7745499
    [Abstract] [Full Text] [Related]

  • 6. Genetic progression, histological grade, and allelic loss in ductal carcinoma in situ of the breast.
    Fujii H, Szumel R, Marsh C, Zhou W, Gabrielson E.
    Cancer Res; 1996 Nov 15; 56(22):5260-5. PubMed ID: 8912866
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Allelic loss of chromosomal arm 8p in breast cancer progression.
    Anbazhagan R, Fujii H, Gabrielson E.
    Am J Pathol; 1998 Mar 15; 152(3):815-9. PubMed ID: 9502423
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Loss of heterozygosity and microsatellite instability in ductal carcinoma in situ of the breast.
    Ando Y, Iwase H, Ichihara S, Toyoshima S, Nakamura T, Yamashita H, Toyama T, Omoto Y, Karamatsu S, Mitsuyama S, Fujii Y, Kobayashi S.
    Cancer Lett; 2000 Aug 11; 156(2):207-14. PubMed ID: 10880771
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Frequent alterations of chromosome 1 in ductal carcinoma in situ of the breast.
    Munn KE, Walker RA, Varley JM.
    Oncogene; 1995 Apr 20; 10(8):1653-7. PubMed ID: 7731721
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Accumulation of chromosomal imbalances from intraductal proliferative lesions to adjacent in situ and invasive ductal breast cancer.
    Aubele MM, Cummings MC, Mattis AE, Zitzelsberger HF, Walch AK, Kremer M, Höfler H, Werner M.
    Diagn Mol Pathol; 2000 Mar 20; 9(1):14-9. PubMed ID: 10718208
    [Abstract] [Full Text] [Related]

  • 18. Technical approach for the study of the genetic evolution of breast cancer from paraffin-embedded tissue sections.
    Chen T, Dhingra K, Sahin A, Sneige N, Hortobagyi G, Aldaz CM.
    Breast Cancer Res Treat; 1996 Mar 20; 39(2):177-85. PubMed ID: 8872326
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 22.